Proteomic identification of oncogenic chromosomal translocation partners encoding chimeric anaplastic lymphoma kinase fusion proteins.

The anaplastic lymphoma kinase (ALK) on 2p23 is a tyrosine kinase that forms chimeric fusions with numerous translocation partners. We describe a mass spectrometry-based approach for the identification of ALK fusion partners. This approach accurately identified the nucleophosmin (NPM)-ALK fusion protein in an anaplastic large cell lymphoma (ALCL)-derived cell line carrying the t(2;5)(p23;q35), and the TPM3-ALK in a clinical biopsy of inflammatory myofibroblastic tumor (IMT) carrying the t(1;2)(q21;p23). This study shows the ability of mass spectrometry to identify oncogenic chimeric proteins resulting from chromosomal rearrangements. This strategy can be adapted for the identification of known and unknown translocation partners of chimeric ALK fusion proteins involved in oncogenesis.

[1]  D. Hartl,et al.  Genetic applications of an inverse polymerase chain reaction. , 1988, Genetics.

[2]  K. Pulford,et al.  Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis , 1997, Molecular and cellular biology.

[3]  T. Hubbard,et al.  A census of human cancer genes , 2004, Nature Reviews Cancer.

[4]  S. Perkins,et al.  ALK1 and p80 Expression and Chromosomal Rearrangements Involving 2p23 in Inflammatory Myofibroblastic Tumor , 2001, Modern Pathology.

[5]  J. Yates,et al.  Automated identification of amino acid sequence variations in proteins by HPLC/microspray tandem mass spectrometry. , 2000, Analytical chemistry.

[6]  K. Pulford,et al.  Anaplastic lymphoma kinase proteins in growth control and cancer , 2004, Journal of cellular physiology.

[7]  A T Look,et al.  Oncogenic transcription factors in the human acute leukemias. , 1997, Science.

[8]  C. Naeve,et al.  ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK) , 1997, Oncogene.

[9]  J. Yates,et al.  An automated multidimensional protein identification technology for shotgun proteomics. , 2001, Analytical chemistry.

[10]  P. Watkins,et al.  Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8;21) leukemic cells. , 1992, Cancer genetics and cytogenetics.

[11]  P. Nowell,et al.  Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[12]  John I. Clark,et al.  Shotgun identification of protein modifications from protein complexes and lens tissue , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Mason,et al.  Anaplastic lymphoma kinase proteins and malignancy , 2001, Current opinion in hematology.

[14]  J. Rowley,et al.  Chromosome translocations: dangerous liaisons revisited , 2001, Nature Reviews Cancer.

[15]  A. Ullrich,et al.  The discovery of receptor tyrosine kinases: targets for cancer therapy , 2004, Nature Reviews Cancer.

[16]  M. Frohman,et al.  On beyond classic RACE (rapid amplification of cDNA ends). , 1994, PCR methods and applications.

[17]  S. Winistorfer,et al.  Sequence specific generation of a DNA panhandle permits PCR amplification of unknown flanking DNA. , 1992, Nucleic acids research.

[18]  Alan L Rockwood,et al.  Sequence alignment by cross-correlation. , 2005, Journal of biomolecular techniques : JBT.

[19]  K. Pulford,et al.  Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation. , 1998, Cancer research.

[20]  M. Frohman,et al.  Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Mann,et al.  The abc's (and xyz's) of peptide sequencing , 2004, Nature Reviews Molecular Cell Biology.

[22]  M. Dyer,et al.  Rapid Molecular Cloning of Rearrangements of the IGHJ Locus Using Long- Distance Inverse Polymerase Chain Reaction , 1997 .

[23]  J. Yates,et al.  Direct analysis of protein complexes using mass spectrometry , 1999, Nature Biotechnology.

[24]  C. Griffin,et al.  Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors. , 1999, Cancer research.

[25]  Jürg Zimmermann,et al.  Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells , 1996, Nature Medicine.

[26]  P. Meltzer,et al.  Mechanisms of sarcoma development , 2003, Nature Reviews Cancer.

[27]  D N Shapiro,et al.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. , 1994, Science.

[28]  T. Rabbitts,et al.  Chromosomal translocations in human cancer , 1994, Nature.

[29]  P. D. Dal Cin,et al.  TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. , 2000, The American journal of pathology.

[30]  T. Arakawa,et al.  Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system , 1997, Oncogene.